VITRUVIAE Collaborator Receives Grant To Study VITRUVIAE Immunotherapies For Pediatric AML

Dec 8, 2024

VITRUVIAE is pleased to announce that Dr. Johannes Zakrzewski, a valued collaborator, has received a research grant from Alex’s Lemonade Stand Foundation to support studies of VITRUVIAE’s trispecific immunotherapy platform for the treatment of pediatric Acute Myeloid Leukemia (AML).

Read more at Alex's Lemonade Stand Foundation

Terms of Service

Privacy Policy

Cookie Policy

© 2025 VITRUVIAE. All rights reserved.